Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Lei

Showing results (451-460 of 469) with videos related to

Pageof 47
Sort By:
International Journal of Molecular Sciences|September 12, 2020
Improved Detection of Antibodies against SARS-CoV-2 by Microsphere-Based Antibody AssayCarol Ho-Yan Fong, Jian-Piao Cai, Thrimendra Kaushika Dissanayake, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2021
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant-Associated Receptor Binding Domain (RBD) Mutations on the Susceptibility to Serum Antibodies Elicited by Coronavirus Disease 2019 (COVID-19) Infection or VaccinationLin-Lei Chen, Lu Lu, Charlotte Yee-Ki Choi, et al.
Signal Transduction and Targeted Therapy|August 12, 2024
Gefitinib (an EGFR tyrosine kinase inhibitor) plus anlotinib (an multikinase inhibitor) for untreated, EGFR-mutated, advanced non-small cell lung cancer (FL-ALTER): a multicenter phase III trialHua-Qiang Zhou, Ya-Xiong Zhang, Gang Chen, et al.
Emerging Microbes & Infections|October 16, 2025
Enhanced replication of a contemporary avian influenza A H9N2 virus in human respiratory organoidsLin-Lei Chen, Jonathan Daniel Ip, Wan-Mui Chan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 16, 2021
Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine RecipientsLu Lu, Bobo Wing Yee Mok, Lin Lei Chen, et al.
American Journal of Translational Research|January 11, 2023
The prognostic value of keratin pearls in patients with esophageal squamous cell carcinomaKan Zhong, Xin Song, Xue Ke Zhao, et al.
Ebiomedicine|August 14, 2023
The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5Huiping Shuai, Jasper Fuk-Woo Chan, Bingjie Hu, et al.
Cell|May 20, 2017
Immunization-Elicited Broadly Protective Antibody Reveals Ebolavirus Fusion Loop as a Site of VulnerabilityXuelian Zhao, Katie A Howell, Shihua He, et al.
The Lancet. Microbe|November 24, 2020
Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort studyKelvin Kai-Wang To, Vincent Chi-Chung Cheng, Jian-Piao Cai, et al.
Ebiomedicine|April 10, 2022
Boosting of serum neutralizing activity against the Omicron variant among recovered COVID-19 patients by BNT162b2 and CoronaVac vaccinesLu Lu, Lin-Lei Chen, Ricky Rui-Qi Zhang, et al.
Pageof 47

Showing results (451-460 of 469) with videos related to

Sort By:
Pageof 47
International Journal of Molecular Sciences|September 12, 2020
Improved Detection of Antibodies against SARS-CoV-2 by Microsphere-Based Antibody AssayCarol Ho-Yan Fong, Jian-Piao Cai, Thrimendra Kaushika Dissanayake, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2021
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant-Associated Receptor Binding Domain (RBD) Mutations on the Susceptibility to Serum Antibodies Elicited by Coronavirus Disease 2019 (COVID-19) Infection or VaccinationLin-Lei Chen, Lu Lu, Charlotte Yee-Ki Choi, et al.
Signal Transduction and Targeted Therapy|August 12, 2024
Gefitinib (an EGFR tyrosine kinase inhibitor) plus anlotinib (an multikinase inhibitor) for untreated, EGFR-mutated, advanced non-small cell lung cancer (FL-ALTER): a multicenter phase III trialHua-Qiang Zhou, Ya-Xiong Zhang, Gang Chen, et al.
Emerging Microbes & Infections|October 16, 2025
Enhanced replication of a contemporary avian influenza A H9N2 virus in human respiratory organoidsLin-Lei Chen, Jonathan Daniel Ip, Wan-Mui Chan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 16, 2021
Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine RecipientsLu Lu, Bobo Wing Yee Mok, Lin Lei Chen, et al.
American Journal of Translational Research|January 11, 2023
The prognostic value of keratin pearls in patients with esophageal squamous cell carcinomaKan Zhong, Xin Song, Xue Ke Zhao, et al.
Ebiomedicine|August 14, 2023
The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5Huiping Shuai, Jasper Fuk-Woo Chan, Bingjie Hu, et al.
Cell|May 20, 2017
Immunization-Elicited Broadly Protective Antibody Reveals Ebolavirus Fusion Loop as a Site of VulnerabilityXuelian Zhao, Katie A Howell, Shihua He, et al.
The Lancet. Microbe|November 24, 2020
Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort studyKelvin Kai-Wang To, Vincent Chi-Chung Cheng, Jian-Piao Cai, et al.
Ebiomedicine|April 10, 2022
Boosting of serum neutralizing activity against the Omicron variant among recovered COVID-19 patients by BNT162b2 and CoronaVac vaccinesLu Lu, Lin-Lei Chen, Ricky Rui-Qi Zhang, et al.
Pageof 47